SCHEMBL15740331

SCHEMBL15740331

CC(C)(C)c1ccc(NS(=O)(=O)c2ccc(N)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 1.00
ALDH1A1 P00352 3/20 1.00
MEN1 O00255 2/20 1.00
MAPT P10636 2/20 1.00
CYP1A2 P05177 1/20 1.00
CYP3A4 P08684 1/20 1.00
CYP2C19 P33261 1/20 1.00
CA1 P00915 3/20 0.77
CA2 P00918 3/20 0.77
UQCRB P14927 1/20 0.71
HTT P42858 2/20 0.65
CA9 Q16790 1/20 0.65
HDAC3 O15379 2/20 0.64
HDAC11 Q96DB2 2/20 0.64
HDAC8 Q9BY41 2/20 0.64
HDAC6 Q9UBN7 2/20 0.64
RORA P35398 1/20 0.64
FFAR1 O14842 1/20 0.62
FFAR4 Q5NUL3 1/20 0.62
KEAP1 Q14145 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20657557 1.00 KMT2A (1.00) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL812679 0.91 ALDH1A1 (0.83) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL540915 0.86 CA1 (0.85) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL11793140 0.86 CA1 (0.85) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL13433558 0.85 ALDH1A1 (0.73) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL1040954 0.85 ALDH1A1 (0.73) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL7178237 0.83 UQCRB (1.00) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL95623 0.83 ALDH1A1 (0.71) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL27811906 0.83 ALDH1A1 (0.71) KMT2AALDH1A1MEN1MAPTCYP1A2
SCHEMBL4573249 0.83 KMT2A (0.71) KMT2AALDH1A1MEN1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014081856-A2 LIGANDS THAT TARGET HCV-E2 BINDING SITES ON CD81 AND THERAPEUTIC METHODS USING THEM AZZAZY HASSAN (EG) 2014-05-30 WO disclosed